Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.955
-0.043 (-4.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Spero Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 52 | 78 | 90 | 518 | 527 | 184 | |
| Market Cap Growth | 13.54% | -13.02% | -82.69% | -1.83% | 186.63% | 73.81% | |
| Enterprise Value | -20 | -10 | 46 | 401 | 408 | 95 | |
| Last Close Price | 0.96 | 1.47 | 1.73 | 16.01 | 19.39 | 9.62 | |
| PE Ratio | 14.75 | 3.42 | - | - | - | - | |
| PS Ratio | 0.48 | 0.75 | 1.67 | 28.35 | 56.50 | 10.13 | |
| PB Ratio | 0.79 | 0.73 | 1.18 | 5.86 | 3.99 | 2.47 | |
| P/TBV Ratio | 1.11 | 0.73 | 1.18 | 5.86 | 3.99 | 2.47 | |
| EV/Sales Ratio | 0.13 | - | 0.86 | 21.98 | 43.72 | 5.24 | |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.09 | 0.63 | 0.06 | 0.07 | |
| Debt / EBITDA Ratio | 9.28 | 0.19 | - | - | - | - | |
| Asset Turnover | 0.88 | 0.68 | 0.36 | 0.11 | 0.07 | 0.15 | |
| Quick Ratio | 2.64 | 3.42 | 5.09 | 7.98 | 9.28 | 3.40 | |
| Current Ratio | 2.68 | 3.53 | 5.25 | 8.46 | 9.70 | 3.58 | |
| Return on Equity (ROE) | 5.89% | 24.95% | -56.53% | -81.47% | -75.77% | -63.99% | |
| Return on Assets (ROA) | -0.57% | 10.90% | -12.91% | -33.88% | -38.10% | -33.61% | |
| Return on Capital (ROIC) | -1.06% | 17.17% | -16.86% | -38.73% | -44.95% | -40.32% | |
| Earnings Yield | 6.75% | 29.27% | -51.82% | -17.34% | -14.85% | -33.13% | |
| FCF Yield | -33.68% | -42.35% | -8.63% | -12.43% | -16.32% | -27.37% | |
| Buyback Yield / Dilution | -4.41% | -40.98% | -21.65% | -38.01% | -23.27% | -13.49% | |
| Total Shareholder Return | -4.41% | -40.98% | -21.65% | -38.01% | -23.27% | -13.49% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.